Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jun 5, 2007

Valeant Pharmaceuticals Sells Manufacturing Facilities in Switzerland and Puerto Rico

  • Valeant Pharmaceuticals signed an agreement to sell its manufacturing facilities in Humacao, Puerto Rico, and Basel, Switzerland, to Legacy Pharmaceuticals. Terms of the transaction were not disclosed. Additionally, the sale includes the divestiture of the company’s product Reptilase.

    “The sale of the two manufacturing sites in Basel and Humacao represents the final step in our restructuring initiative, most of which was completed last year,” reported Timothy C. Tyson, Valeant's president and CEO.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »